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ABSTRACT
Objective: The present study represents the development of two spectrophotometric methods for the determination of carisoprodol (CCP) in pure 
and formulations using ferric chloride, o-phenanthroline, and p-nitroaniline (PNA), sodium nitrate as analytical reagents.
Methods: The proposed spectrophotometric methods were developed based on oxidation of Fe3+ by CCP, and then, the resultant product was reacted 
with o-phenanthroline in acidic condition forms an orange-colored complex and diazotization of PNA followed by coupling with CCP in an alkaline 
medium forms yellow-colored complex.
Results: Under the optimized conditions, the absorbance of CCP concentration obeyed the Beer’s law in the ranges of 10–60 μg/mL with good 
correlation coefficient values of 0.9992 and 0.9990 with the limit of detection values of 1.286 and 2.408 μg/mL, respectively.
Conclusion: The proposed methods were successfully applied for the determination of CCP in pure and in their formulations.
Keywords: Ferric chloride, o-Phenanthroline, p-Nitroaniline, Sodium nitrate, Spectrophotometry, Analysis.
INTRODUCTION
Carisoprodol (CCP) is a skeletal muscle relaxant belonging to 
monocarboxylic acids and derivatives class of organic compounds [1] 
that have both sedative and skeletal muscle relaxant effects [2]. 
The mechanism of CCP is not known exactly. Along with rest and 
physical therapy, CCP is also used in the treatment of injuries 
and painful musculoskeletal conditions [3,4]. CCP chemically 
known as [2-(carbamoyloxymethyl)-2-methylpentyl] N-propan-
2-ylcarbamate (Fig. 1). The detailed survey of literature revealed 
that few methods have been reported for the estimation of CCP 
by liquid chromatography-tandem mass spectrophotometry [5], 
gas chromatography [6,7], homogeneous immunoassay [8], high-
performance thin-layer chromatography [9], liquid chromatography/
mass spectrophotometry [10], and ultraviolet (UV)-high-performance 
liquid chromatography [11]. The above reported chromatographic 
methods employed sophisticated and expensive instrumentation. 
Hence, UV-visible spectrophotometric methods are preferred for the 
precise, accurate, and cost-effective determination of pharmaceutical 
substances. There are three extractive spectrophotometric methods 
that have been reported for the assay of CCP in pure and pharmaceutical 
formulations [12]. However, the above methods were suffered from one 
or the other disadvantage such as poor sensitivity, unstable color, and 
rigid experimental conditions.
By considering into the above disadvantages of the reported 
methods, the present investigation was aimed to develop and validate 
some simple, sensitive, precise, accurate, and economical visible 
spectrophotometric methods.
In the present investigation, two simple and sensitive visible 
spectrophotometric methods (method-A and method-B) were 
developed and validated for the analysis of CCP with broad linearity, 
good precision, and accuracy. These methods could be applied for the 
quantitative determination of the CCP in their tablet formulations.
METHODS
Instrumentation
An ELICO (Hyderabad, India) double beam model SL 244 digital 
spectrophotometer with 1 cm matched quartz cell was used for the 
spectral and absorbance measurements. A Coslab (Ambala Cantt, India) 
CLE-105 model water bath was used to control the temperature and a 
Shimadzu (Tokyo, Japan) electronic weighing balance, model BL 220 H, 
was used for weighing the samples.
Chemicals and reagents
All reagents and chemicals were of analytical reagent grade and used 
as received. All the solutions were prepared fresh daily using double 
distilled water. Aqueous solutions of 0.2% (w/v) o-phenanthroline, 
0.54% (w/v) ferric chloride, 0.2 M (v/v) orthophosphoric acid 
(Merck Specialties Pvt., Ltd., Mumbai, India), 0.2 M HCl (v/v), 0.1% 
p-nitroaniline (PNA), and 0.4% (w/v) and 4% (w/v) sodium hydroxide 
(SD-Fine Chemicals Ltd., Mumbai, India) prepared in the usual way.
Stock and working standard solutions
Analytically pure CCP was obtained as a gift sample from the Aurobindo 
Laboratories Pvt., Ltd., (India) and was used as received. The stock 
solution of CCP was prepared by dissolving 100 mg of CCP in 20 ml of 
methanol in a 100 ml volumetric flask and then make up to the mark with 
distilled water (1.0 mg/ml). The stock solution was diluted stepwise 
with the same distilled water to obtain working standard solutions of 
concentration of 200 μg/mL for methods A and B, respectively.
General assay procedure
Method-A
Delivered aliquots of standard CCP (0.5–3.0 ml, 200 µg/ml) into 10 ml 
calibrated tubes. To each tube, 1.0 ml of 0.2% O-PHEN was added followed 
by 1.0 ml of 0.54% FeCl3 solution. The contents of the tubes were mixed 
well and the resulting solution was heated for 15 min at 100°C, and then, 
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2.0 ml of 0.2 M orthophosphoric acid was added. The volume in each tube 
was made up to the mark with distilled water and the absorbance of the 
colored solution was measured at 495 nm against a reagent blank.
Method-B
To a set of 10 ml calibrated tubes, aliquot volumes (0.5–3.0 ml) of CCP 
standard solution (200 µg/ml) were quantitatively transferred. To 
each tube, 0.8 ml of 0.1% PNA followed by 1.0 ml of 0.4% NaNO2 were 
added and mixed well. The solutions were kept aside for 20 min. Then, 
2.0 ml of 4% NaOH was added and again kept aside for 30 min. After the 
specified time, the tubes were made up to volume with distilled water. 
The absorbance was measured at 445 nm against a reagent blank.
In both the methods, the calibration graphs were plotted against the 
absorbance with the final concentration of the CCP (μg/mL).
Procedure for the assay of CCP in pharmaceutical formulations 
(tablets)
The tablet formulation of CCP, Pain O Soma® (HAB Pharmaceuticals and 
Research Ltd., Dehradun, India) labeled to contain 250 mg and 350 mg 
was purchased from a local pharmacist. 10 tablets of each were accurately 
weighed, finely powdered, and mixed well. A portion of the powder 
equivalent to 100 mg of CCP was transferred into 100 ml volumetric 
flasks, about 30 ml methanol was added and the contents of the flask were 
sonicated for 15 min. The volume was made with distilled water, mixed, and 
filtered using Whatman No. 1 filter paper. Aliquots covering the working 
concentration ranges of proposed methods were prepared with distilled 
water. The procedures described under general analytical procedure were 
followed. The nominal contents of the CCP in tablets were calculated using 
the corresponding calibration curve or regression equation.
RESULTS AND DISCUSSION
Method-A
The reaction of FeCl3 and o-phenanthroline with the amino group has 
been reported for some amino group containing drugs. The results 
of those reactions demonstrated that the combination of FeCl3 and 
o-phenanthroline is one of the good chromogenic reagents in the 
development of spectrophotometric methods for the determination 
of many drugs containing amine groups [13-18]. In this present 
developed method, CCP was reacted with ferric chloride under suitable 
experimental conditions which convert ferric chloride into ferrous salt, 
the amount of conversion correlated to the drug concentration. These 
ferrous ions react with o-phenanthroline to form orange-red-colored 
chromogen (Scheme. 1) with maximum absorption at 495 nm (Fig. 2) 
by obeying Beer’s law in the concentration range of 10–60 µg/mL.
Method-B
PNA is a well-known reagent to react with amines to form the stable 
diazo complex. In the presence of sodium nitrite and Hcl, PNA) acts 
as a chromogenic reagent, which has been used for the determination 
of various drugs containing amino groups [14,18-22]. In the present 
investigation, PNA undergoes diazotization followed by coupling with 
CCP in the alkaline medium by the formation of the yellow-colored 
complex (Scheme. 2) with λ maximum at 445 nm (Fig. 3) by obeying 
Beer’s law in the concentration range of 10–60 µg/mL.
OPTIMIZATION OF THE EXPERIMENTAL CONDITIONS
Method-A
Various factors affect the reaction between the CCP and reagents including 
FeCl3, o-PHEN, and o-phosphoric acid concentrations, temperature, and 
heating time. These were studied to optimize the reaction conditions 
and to give maximum absorbance. All these optimum values of various 
factors were maintained throughout the experiment.
Effect of FeCl3 volume
The effect of 0.54% FeCl3 on the absorbance of the orange-colored complex 
was studied in the range of 0.5–3.0 mL. The absorbance of the complex 
increased with the increase in the volume of FeCl3 up to 1.0 mL. Further, 
Scheme 1: Reaction of carisoprodol with FeCl3 and o-phenanthroline
Fig. 1: Structure of carisoprodol
Fig. 2: Absorption spectrum of carisoprodol with FeCl3 and 
o-phenanthroline
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addition of FeCl3 showed a decrease in the absorbance. Therefore, 1.0 mL 
of 0.54% FeCl3 was considered as an optimum value (Fig. 4).
Effect of o-phenanthroline concentration
The effect of the concentration of o-phenanthroline was studied by 
conducting reaction between 10 μg/mL CCP, 1 mL of FeCl3 and varying 
volumes (0.5–3.0 ml) of 0.2% o-PHEN and 2.0 ml of 0.2 M o-phosphoric 
acid. The reaction indicates that the absorbance of the CCP-FeCl3 and 
o-PHEN complex was increased by increasing the volume of 0.2% 
o-PHEN up to 0.9 ml; later, it became constant at 1.0 mL. Further 
increase in the volume, there was no change in the absorbance (Fig. 5). 
Therefore, 1 mL of 0.2% o-PHEN solution was chosen as the optimal 
volume for the development of the colored complex.
Effect of the concentration of orthophosphoric acid
The concentration of 0.2 M orthophosphoric acid effect on the absorbance 
of the orange-colored complex was studied in the range of 0.5–5.0 ml. The 
absorbance increased with the increasing the volume of orthophosphoric 
acid and became constant at 2.0 ml. Further, addition of orthophosphoric 
acid did not show any change in the absorbance (Fig. 6).
Effect of temperature
The effect of the temperature on the orange-colored complex was 
studied between the temperatures 30–110°C. The maximum absorbance 
Scheme. 2: Reaction of carisoprodol with PNA
Fig. 3: Absorption spectrum of carisoprodol with p-nitroaniline 
and NaNO2
Fig. 4: Effect of the volume of FeCl3
Fig. 5: Effect of the concentration of o-phenanthroline
Fig. 6: Effect of the concentration of o-phosphoric acid
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was attained when the temperature reached 100°C. Further increasing 
the temperature >100°C, the intensity of the color and the absorbance 
started to decrease (Fig. 7).
Effect of time
Time also one of the important factors which affect chemical reactions. 
In the present investigation, the effect of heating time on the formation 
of the orange-colored complex was also studied and optimized. At room 
temperature, the intensity of the color increased by the increasing the 
time, maximum absorbance was obtained at 15 min and remained 
constant for 30 min. After 30 min of the time interval, the increase in 
the heating time did not cause any change in intensity of color (Fig. 8).
Method-B
In this method, PNA carried out diazotization reaction with NaNO2 under 
acidic conditions followed by coupling with the CCP. The experimental 
conditions were optimized by studying the effect of various parameters 
such as volume and concentrations of PNA, NaNO2, and NaOH for the 
maximum color development and the time required for diazotization 
and diazo coupling.
Effect of the concentration of 0.1% PNA
To the study of the effect of the concentration of 0.1% p-nitroaniline 
for yellow-colored development, different volumes (0.2–2.0 ml) of 
0.1% PNA were mixed with different volumes of CCP (10 μg/mL) and 
followed by 1.0 ml of 0.4% NaNO2, and then, 2.0 ml of 4% NaOH was 
added. The study indicates that the addition of 0.8 ml of 0.1% PNA 
gave the maximum absorbance, which remained constant up to 2.0 ml. 
Therefore, 0.8 ml of the 0.1% PNA was chosen for the determination of 
the CCP for the present experiment (Fig. 9).
Effect of the volume of NaNO2
The effect of the volume of 0.4% NaNO2 was studied during the 
formation of yellow color. This study carried out by addition of an 
aliquot of CCP containing 10 μg/ml to different volumes (0.5–3.0 ml) of 
0.4% NaNO2 and 0.8 ml of 0.1% PNA and then 2.0 ml of 0.4% NaOH. The 
results were shown that the maximum absorbance was attained with 
1.0 ml of 0.4% NaNO2. Further, addition of NaNO2 showed decrease in 
the absorbance. Therefore, 1.0 ml of 0.4% NaNO2 was used throughout 
the experiment (Fig. 10).
Effect of time for diazotization
To study the effect of time for diazotization, 1 mL of CCP (10 μg/mL) 
and 0.8 ml of 0.1% PNA followed by 1.0 ml of 0.4% NaNO2 were added 
and mixed well. Later, the solutions were kept aside for 20 min. Color 
intensity was obtained maximum at 20 min. Further, increase in time no 
effect on diazotization. Hence, 20 min was chosen as the optimum time 
for diazotization (Fig. 11).
Effect of the volume of NaOH
The effect of the volume of 4% sodium hydroxide on yellow color 
formation was studied by addition of different volumes (0.5–4.0 ml) of 
4% sodium hydroxide to an aliquot of CCP (10 μg/ml) and mixed well 
then added 0.8 ml of 0.1% PNA followed by 1.0 ml of 0.4% NaNO2 to 
that mixture. The solutions were kept aside for 20 min. The results are 
presented in Fig. 12, which indicate that the addition of 2.0 ml of 4% 
NaOH gave the maximum absorbance, which remained constant up to 
Fig. 7: Effect of temperature
Fig. 8: Effect of time
Fig. 9: Effect of the concentration of p-nitroaniline
Fig. 10: Effect of the volume of NaNO2
Fig. 11: Effect of time for diazotization
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3.0 ml later started to decrease. Therefore, 2.0 ml of the 4% NaOH was 
chosen for the quantification of the CCP throughout the experiment.
Effect of time for diazo coupling
To study the effect of time for diazo coupling, 1 mL of CCP (10 μg/mL) 
and 0.8 ml of 0.1% PNA followed by 1.0 ml of 0.4% NaNO2 were added 
and mixed well. The solutions were kept aside for 20 min. Then, 2.0 ml 
of 4% NaOH was added and again kept aside for 30 min. Diazo coupling 
was completed at 30 min. Hence, 30 min was chosen as optimum time 
(Fig. 13).
VALIDATION OF THE DEVELOPED METHODS
The developed methods were validated by following the ICH 
guidelines [23]. Various parameters including linearity, sensitivity, 
precision, accuracy, and robustness were studied.
Linearity
Linearity was studied in the concentration range from 10 to 60 μg/mL 
for methods - A and B, respectively. The drug showed good linearity in 
the tested range. The regression coefficient values for methods - A and B 
were found to be >0.9989. The obtained results have a good and dynamic 
linearity range of the developed methods.
Sensitivity
The sensitivity of the proposed methods was estimated in terms of 
Sandell’s sensitivity, limit of quantitation, limit of detection, and molar 
absorptivity. The results are presented in Table 1, the results showed 
the high sensitivity of the developed methods.
Accuracy and precision
Precision and accuracy were investigated by analyzing different 
concentrations of CCP (10, 30, and 60 µg/ml) - for both methods 
(methods - A and B) in five independent replicates on the same day 
(intraday precision and accuracy) and on 3 consecutive days (interday 
precision and accuracy). The data are represented as the relative 
standard deviation (%RSD) and percent recovery for precision and 
accuracy, respectively. The results have shown in Tables 2 and 3. 
Low RSD (<1.0) values and good recovery values for intra- and inter-
day analysis show good precision and accuracy data of the proposed 
methods (methods - A and B), respectively.
RECOVERY STUDIES
The accuracy of the proposed methods was further determined by 
the standard addition method. A known amount of CCP at three 
different levels (5, 100, and 150%) was added to the pre-analyzed 
sample solution and the amount of CCP was estimated by the reported 
methods. The results were reported as the RSD and percent recovery 
are shown in Table 4. The recovery studies showed that there was no 
interference from excipients in the determination of the CCP by the 
proposed methods.
Robustness
The robustness of the proposed methods was studied by making small 
changes in the experimental parameters at two different concentration 
levels (10 and 60 μg/mL). The results are presented in Table 5. The 
results showed that the slight changes did not adversely influence the 
absorbance intensity.
Fig. 12: Effect of the volume of NaOH
Fig. 13: Effect of time for diazo coupling
Table 1: Optical and regression characteristics of the proposed 
methods
Parameters Method-1 Method-2
λ max 495 445
Beer’s limit (μg/mL) 10–60 10–60
Molar absorptivity (L mole-1 cm−1) 2.874×103 7.078×103
Sandell’s sensitivity (μg cm−2/0.001 
Absorbance unit)
0.2032 0.1960
Stability of colored products (mins) 50 70
Regression equation (Y=mx+c)**
Slope (m) 0.005 0.005
Intercept (c) −0.0016 0.0030
Regression coefficient (r2) 0.9992 0.9990
LOD (μg/mL) 1.286 2.408
LOQ (μg/mL) 3.898 7.298
**Y=mx+c, Where y is the absorbance and x is the concentration of drug in 
μg/mL. LOD: Limit of detection, LOQ: Limit of quantification
Table 2: Intraday precision and accuracy
Method Amount of CCP (µg/mL) RSD (%) Recovery (%) Error (%)
Taken Found*±SD
1 10 10.035±0.047 0.473 100.35 0.35
30 30.030±0.062 0.209 100.10 0.10
60 60.020±0.057 0.095 100.03 0.03
2 10 10.003±0.025 0.259 100.03 0.03
30 30.015±0.040 0.135 100.05 0.05
60 60.016±0.066 0.110 100.02 0.02
*Average five determinations. CCP: Carisoprodol, SD: Standard deviation, RSD: Relative standard deviation
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APPLICATION OF THE PROPOSED METHODS TO ANALYSIS OF CCP 
IN TABLET FORMULATIONS
From the above-mentioned results, the proposed methods gave 
satisfactory results with CCP in bulk. Therefore, the proposed 
methods were successfully applied for the determination of CCP in 
their formulations. The results are shown in Table 6. The percent 
recovery and %RSD clearly showed no interference of any excipients of 
formulation, thus proving accuracy and precision in the quantification 
of CCP by both methods.
Table 3: Interday precision and accuracy
Method Amount of CCP (μg/mL) RSD (%) Recovery (%) Error (%)
Taken Found*±SD
1 10 10.035±0.067 0.675 100.35 0.35
30 30.036±0.059 0.199 100.12 0.12
60 59.991±0.015 0.026 99.98 -0.02
2 10 10.006±0.086 0.864 100.06 0.06
30 30.013±0.050 0.168 100.04 0.04
60 59.998±0.012 0.020 99.99 -0.01
*Average five determinations. CCP: Carisoprodol, SD: Standard deviation, RSD: Relative standard deviation
Table 4: Results of recovery studies by standard addition technique
Method Amount of CCP mg Found* RSD (%) Recovery (%)
Tablet Spiked
1 10 5 14.992 0.619 99.94
10 10 20.005 0.055 100.02
10 15 25.006 0.046 100.03
2 10 5 15.018 0.131 100.08
10 10 20.022 0.116 100.11
10 15 25.007 0.032 100.29
*Average of three determinations, CCP: Carisoprodol, RSD: Relative standard deviation
Table 5: Results of robustness of the proposed methods
Method Parameter Concentration of CCP (μg/ml) SD Recovery (%) RSD (%)
Taken Found*
1 Volume of 0.2%
O-PHEN (1.0±0.1 ml)
10 10.01 0.032 100.10 0.323
60 59.99 0.025 99.98 0.042
Volume of 0.54% FeCl3 (1.0±0.1 ml) 10 9.99 0.007 99.90 0.070
60 60.01 0.029 100.01 0.049
Volume of 0.2 M H3PO4 (2.0±0.2 ml) 10 10.02 0.041 100.20 0.414
60 59.99 0.021 99.98 0.036
Temperature
(100±5°C)
10 10.03 0.051 100.30 0.513
60 60.01 0.025 100.01 0.042
Boiling time
(15±2 min)
10 10.02 0.037 100.20 0.373
60 60.01 0.033 100.01 0.056
2 Volume of 0.1% PNA (0.8±0.1 ml) 10 9.96 0.033 99.60 0.336
60 60.01 0.036 100.01 0.060
Volume of 0.4% NaNO2 (1.0±0.1 ml) 10 10.02 0.039 100.20 0.392
60 60.03 0.053 100.05 0.089
Volume of 4% NaOH (2.0±0.2 ml) 10 9.98 0.020 99.80 0.200
60 60.01 0.012 100.01 0.020
Diazotization time
(20±2 min)
10 10.06 0.041 100.60 0.415
60 60.11 0.069 100.18 0.115
Diazo coupling time
(30±2 min)
10 10.06 0.042 100.60 0.424
60 60.13 0.077 100.21 0.129
CCP: Carisoprodol, SD: Standard deviation, RSD: Relative standard deviation
Table 6: Results of the analysis of CCP in tablet formulations
Method Labeled claim (mg) Found* SD % RSD % recovery t-value$ F-value$$
1 250 250.03 0.040 0.016 100.012 0.097 3.195
350 350.06 0.052 0.015 100.017 0.116 4.616
2 250 249.973 0.023 0.094 99.989 0.465 2.353
350 350.015 0.032 0.092 100.004 0.988 3.082
3@ 250 250.09 0.025 0.071 100.036 ---- ----
350 249.91 0.034 0.067 99.964 ---- ----
*Average of three determinations. $tabulated t value - 2.306. $$tabulated F value - 6.39. @Reference method. CCP: Carisoprodol, SD: Standard deviation, RSD: Relative 
standard deviation
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CONCLUSION
In the present investigation, there are two simple, rapid, cost-effective, 
accurate, precise, and robust spectrophotometric methods developed 
for the estimation of CCP, using FeCl3, o-phenanthroline, and PNA, NaNO2 
as analytical reagents in bulk drug and tablet forms. The developed 
methods have the advantages over the reported spectrophotometric 
methods in being more sensitive, cost-effective, robust, precise, and 
accurate. Furthermore, the developed methods are inexpensive and do 
not require sophisticated instrumentation and elaborate treatments 
allied with chromatographic methods. Therefore, the proposed 
methods are applied for the routine analysis of CCP in quality control 
laboratories.
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